Dr. Reddy's

Rigel received an upfront cash payment, and is eligible for regulatory and commercial milestone payments, and tiered royalty payments on net sales of REZLIDHIA in the territory.

*Includes Latin America, South Africa, certain countries in the Commonwealth of Independent States (CIS), India, certain countries in Southeast Asia and North Africa, Australia and New Zealand